MedCity News May 11, 2021
Elise Reuter

The companies are supporting 12 culturally competent healthcare startups in a new accelerator. Two of them will get up to $200,000 in grant funding.

A new accelerator launched by Johnson & Johnson and Village Capital is focusing on health equity by focusing on startups delivering culturally competent care.

A dozen startups will join the program, with each taking its own approach to connecting patients to providers and solutions that consider their cultural context.

“Coronavirus has further exacerbated and really called attention to health inequities that we see in the U.S.,” said Heather Matranga, Village Capital’s senior director of strategic innovation in a Zoom interview. “So much of that is around structural issues within the healthcare system as well as...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Trends
Gilead bets on Xilio cancer drug as biotech restructures
Pfizer shifts creative to Publicis in latest marketing move
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Joseph La Barge On The Challenges Of Advancing Gene Therapy, Finding The Right Support
Walgreens Suffers $6 Billion Loss As VillageMD Clinic Investment Sours

Share This Article